Renchin Wu

Critic
DISC Type : C

Director, Pathology Core Laboratory at Dana-Farber Cancer Institute

Greater Boston, United States

Overview

Renchin Wu is a pathologist and physician-scientist at the Dana-Farber Cancer Institute, focused on translational research in gynecologic and gastrointestinal diseases. With a PhD from The Johns Hopkins University School of Medicine, he applies his expertise in molecular pathology and bioinformatics to validate biomarkers for enhanced cancer care.

His professional interests include major pharmaceutical firms like Pfizer and Johnson & Johnson, indicating a focus on the broader healthcare ecosystem and potential industry collaborations. He has also engaged with specialized training, such as the Pharma and CRO Spatial Summit Series, to stay current with industry trends.

He won the Novo Nordisk InnoCentive Challenge for his work on the histologic image analysis of pancreatic tissue.

Personality Overview

Precise

Information Seeker

Critic

It is very likely that they will negotiate pricing or other important terms.  They like to do things independently and don’t look for support from others. Unless the value is proven by data, they are unlikely to value fancy features.

Topics They Care About

Translational Research
His primary focus is translating research findings in gynecologic and gastrointestinal diseases into practical applications that benefit patients.
Biomarker Validation
He collaborates with scientists to identify and validate biomarkers that can significantly improve cancer diagnosis, treatment, and patient outcomes.
Digital Pathology
In a previous role, he successfully validated and implemented a digital pathology diagnostic platform in a high-volume, CAP-accredited laboratory.

Media Appearances

Dana-Farber Pathology Core – Advancing Research and Clinical Diagnostics. Featured in Dana-Farber Cancer Institute

See Now

Work History

7-2025
Director, Pathology Core Laboratory at Dana-Farber Cancer Institute
1-2025
Pathology Research Science Manager at Dana-Farber Cancer Institute
12-2023 - 11-2024
Deputy Director of Inflammatory Bowel Disease Center at Chang Gung Memorial Hospital
2-2021 - 11-2024
Associate Professor at Chang Gung University
10-2020 - 11-2024
Medical Director of Molecular Pathology at Chang Gung Memorial Hospital

Education

Doctor of Philosophy - PhD from The Johns Hopkins University School of Medicine
Doctor of Medicine (M.D.) from Chang Gung University

More Information

Social Presence :

Prographics :

Exp : 15 Location : Greater Boston, United States Job Level : Mid-senior Designation : Director, Pathology Core Laboratory at Dana-Farber Cancer Institute
URL has been copied!

Insights For Selling To Renchin

During A Call Or A Meeting

DO's

  • Be ready to answer many clarity-seeking questions and requests for information
  • Tell them what ROI they can expect
  • Keep some extra margin while sharing pricing, they are likely to negotiate later

DONT's

  • Don't give superficial answers, they are easily rattled by them
  • Don’t try too hard to build a relationship with them
  • Avoid phrases like ‘trust me’, ‘others just love’ etc.

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Renchin is

  • Proven ROI, pricing and objective proof points are the factors that sway their decision.
  • Will you ever get a clear answer from Renchin

  • They are comfortable saying no if they are convinced that it is the correct decision.

Insights For Deal Planning

    How fast (or slow) will Renchin move?

  • Their decision-making is neither very fast nor very slow, they are somewhere in between.
  • Can Renchin take some risk or not?

  • They can take risks if their analysis shows that it would be worth it.

You And Renchin

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.